Merck & Co. has picked up options on two Evaxion Biotech vaccine candidates, paying $3.2 million and dangling more than $1 billion in milestones for the chance to pick up preclinical prospects ...

is set to be available in veterinary clinics and hospitals across the United States this fall. NOBIVAC NXT FeLV is the first FeLV vaccine leveraging Merck's RNA-particle platform, similar to the ...

Innovative technology represents a breakthrough scientific achievement for one of the most common feline infectious diseases RAHWAY, N.J., September 24, 2024--(BUSINESS WIRE)--Merck Animal Health ...

Merck & Co will help make rival Johnson & Johnson's single-shot Covid-19 vaccine in a partnership set to be announced on Tuesday by US President Joe Biden, a White House official said. J&J's ...

A class-action lawsuit claims Merck overcharged for a less potent mumps vaccine, violating the Sherman Act. The District Court denied Merck's summary judgment, acknowledging ethical issues but ...

Merck’s ongoing pneumococcal vaccine development program is designed to provide options that address the specific needs of different populations, including infants and children, healthy adults ...

Prevention of Equine Rotavirus Group B could be getting closer. The virus can cause severe diarrhea and gut lining damage in ...

The global veterinary biologics market is on a robust growth trajectory, with its valuation expected to reach USD 13,140.6 ...

There is also growing global concern about antimicrobial resistance in agriculture and veterinary ... virus. Merck Animal ...

Vaccines – If your dog is not vaccinated ... are at a lower risk for developing cancer, according to a Merck Veterinary Manual study. In female dogs, for example, the more heat cycles she experiences ...